Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation

Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation

 

Purpose

From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate state changes in regional brain function, along with a better understanding of the neural networks affected by depression and SD. Here we propose to study a group of N=48 antidepressant-free male and female patients with current depression symptom and N=12 healthy controls with no history of mood disorders before and after SD to provide mechanistic insight into the neural substrates underlying the antidepressant effects of SD. We hypothesize that SD-induced concurrent functional activity and connectivity changes in multiple brain networks related to different depressive symptom dimensions including emotion regulation, attention, arousal, self-referential, and reward processing will underlie the rapid and transient antidepressant effects of SD. Using an ABA design, multimodal brain imaging along with more traditional electroencephalographic (EEG) and neurobehavioral testing data will be acquired at baseline after normal sleep, during one night of total SD, and after one night of recovery sleep using a 5-day in laboratory protocol during which subjects will be continuously monitored by trained staff.

 

  Eligibility
 

Ages Eligible for Study:  

21 Years to 50 Years   (Adult)

Sexes Eligible for Study:  

All

Accepts Healthy Volunteers:  

Yes

Criteria

Inclusion Criteria:

·         Current depression as assessed on the HDRS-17 (for depressed group only)

·         Body mass index within 15% of normal

·         Stable, normally-timed sleep-wake cycle defined by: a. Habitual nocturnal sleep duration between 6h and 9h. b. Habitual morning awakening between 0600h and 0800h.

·         Able to comprehend English, as all questionnaires are in this language

·         Ability to provide informed consent

Exclusion Criteria:

·         Shift work, transmeridian travel or irregular sleep/wake routine in past 60 days

·         A sleep disorder other than insomnia

·         History of bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders

·         No history of depression for the control group.

·         Alcohol or drug abuse in the past year

·         A current smoker.

·         Any acute or chronic, debilitating medical conditions, epilepsy, or thyroid disease.

·         Metallic implants, pacemakers or tattoos, or history of working in metal workshops.

·         Claustrophobic, or intolerant of the scanner environment.

·         For women, pregnancy will exclude participation.

 

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies. 

Please refer to this study by its ClinicalTrials.gov identifier: NCT03169543
 

Contacts

Contact: Holly Barilla

215-746-4384

holly.barilla@uphs.upenn.edu


 

Locations

United States, Pennsylvania

University of Pennsylvania

Recruiting

PhiladelphiaPennsylvaniaUnited States, 19104

Contact: Holly Barilla    215-746-4384    holly.barilla@uphs.upenn.edu   

Sponsors and Collaborators

University of Pennsylvania

Investigators

Principal Investigator:

Philip Gehrman, PhD

University of Pennsylvania